Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LFMD Stock Chart & Stats
$3.84
-$0.50(-9.03%)
At close: 4:00 PM EST
$3.84
-$0.50(-9.03%)
Day’s Range― - ―
52-Week Range$3.43 - $15.84
Previous CloseN/A
Volume302.38K
Average Volume (3M)1.33M
Market Cap
$184.84M
Enterprise Value$298.24M
Total Cash (Recent Filing)$23.79M
Total Debt (Recent Filing)$6.53M
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Mar 16, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding48,135,883
10 Day Avg. Volume2,356,590
30 Day Avg. Volume1,332,713
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)-37.17
Price to Sales (P/S)0.96
P/FCF Ratio34.12
Enterprise Value/Market Cap1.61
Enterprise Value/Revenue1.18
Enterprise Value/Gross Profit1.36
Enterprise Value/Ebitda28.27
Forecast
1Y Price Target
$9.67Price Target Upside151.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)-0.21
Revenue Forecast (FY)$237.22M
Bulls Say, Bears Say
Bulls Say
Debt ReductionThe company paid off all remaining debt of approximately $17M in 3Q25.
Product DiversificationThe company has been diversifying its platform with strong early traction in behavioral health, women’s health, men’s hormone therapy and personalized compounded ED therapies.
Subscriber GrowthThe number of tele-health subscribers increased by 14%, indicating healthy growth in that segment.
Bears Say
Competitive PressureThe virtual weight management program saw a decline due to greater competitive pressure, impacting subscriber numbers negatively.
Revenue MissTotal revenue was $60.2M, representing 12.7% YoY growth yet missing our projection of $62.0M.
Slow Revenue GrowthRevenue growth has slowed due to reduced aggressive marketing of lower-priced compounded products.
LifeMD News
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.43 and its highest was $15.84 in the past 12 months.
What is LifeMD’s market cap?
LifeMD’s market cap is $184.84M.
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Mar 16, 2026 which is in 106 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on Nov 17, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.08.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -0.06.
How many shares outstanding does LifeMD have?
LifeMD has 48,135,883 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went down -13.531%.
Which hedge fund is a major shareholder of LifeMD?
Currently, no hedge funds are holding shares in LFMD
LifeMD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.67 (151.82% Upside)
$9.67 (151.82% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 87%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 44.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $443.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-9.06%
Trailing 12-Months
Company Description
LifeMD
LifeMD (LFMD) is a telehealth company focused on providing patients with convenient access to a range of healthcare services, including telemedicine consultations, prescription medications, and wellness products. The company operates in the digital health sector, leveraging technology to connect patients with licensed medical professionals for various health needs, such as chronic disease management, weight loss, and dermatological treatments. LifeMD's core offerings include virtual consultations, subscription-based treatment plans, and a comprehensive online pharmacy service that allows patients to receive medications directly to their homes.
LFMD Company Deck
LFMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted significant strategic advancements and growth potential, particularly in telehealth and partnerships with major pharmaceutical companies. However, challenges in the weight management category and a decline in gross margin were notable concerns.View all LFMD earnings summariesLFMD Stock 12 Month Forecast
Average Price Target
$9.67
▲(151.82% Upside)
Technical Analysis
Ownership Overview
16.60% Insiders
10.79% Mutual Funds
5.17% Other Institutional Investors
57.81% Public Companies and
Individual Investors